This melting processes requires name and brand changes over time. neuraxpharmcompany pharmaceutical Specializes in the treatment of disorders. central nervous system (CNS)announced this Thursday Lesvi LaboratoriesThe group’s production facility in Sant Joan Despí will be renamed Neuraxpharm Medicines after this. This complete symbolic integration results from the brand umbrella of a factory where the pharmaceutical group develops products for both its own brands and other national and international pharmaceutical companies. Founded in 1979, it was originally part of Invent medicinea Spanish conglomerate merged with Neuraxpharm Germany With more than 280 employees, Laboratorios Lesvi is dedicated to the manufacture of solid oral dosage forms. It has grown by 56% (on the basis of units produced) in the last six years and has made an investment of 30 million Euros by adapting its facilities to production standards.
Facility manager Ramón Sitges Neuraxpharm Medicines, said in a statement, “The name change to Neuraxpharm Pharmaceuticals means the full integration of this important production area of the company into the Group. Our ability to develop and manufacture products of the highest quality is paramount. We are proud to have a consolidated company that can offer this service to the Group and other partners.” In practice, the name change can be interpreted as a commitment to productive integration and connectivity with the workforce.
In February this year, Neuraxpharm completed the acquisition of two consolidated product portfolios from Sanofi, mainly in the CNS area, consisting of 17 molecules representing 38 brands and marketed in more than 50 countries around the world. He also agreed to sell Inke to Keensight Capital. Last year, Neuraxpharm expanded its portfolio by entering digital medical devices and digital health by completing a strategic licensing agreement for its first orphan indication in SNC. Also in 2022, Neuraxpharm expanded its business in Greece and the Netherlands and earlier this year in the Benelux by establishing Neuraxpharm Belgium, which operates in Belgium and Luxembourg. Neuraxpharm has more than 1,000 employees and a direct presence in 20 countries and through partners in 60 countries.